Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2010

01-12-2010 | RESEARCH REPORT

Transcobalamin deficiency caused by compound heterozygosity for two novel mutations in the TCN2 gene: a study of two affected siblings, their brother, and their parents

Authors: Peter H. Nissen, Maria Nordwall, Elke Hoffmann-Lücke, Boe S. Sorensen, Ebba Nexo

Published in: Journal of Inherited Metabolic Disease | Special Issue 3/2010

Login to get access

Abstract

Transcobalamin (TC) deficiency (OMIM# 275350) is a rare, autosomal recessive disorder that presents in early infancy with a broad spectrum of symptoms, including failure to thrive, megaloblastic anemia, immunological deficiency, and neurological symptoms. Here we report a study of a family (parents and three children) with two children suffering from TC deficiency caused by two different mutations in the TCN2 gene. Initially, molecular genetic analysis of genomic DNA revealed a heterozygous mutation in the +1 position of exon 7 (c.1106+1 G > A) in the father and all three children. Bioinformatic analysis indicates that this mutation causes exon skipping, and further experiments supported this hypothesis and suggested that the mutant allele undergoes nonsense-mediated messenger RNA (mRNA) decay. We did not identify further mutations in genomic DNA that could explain TC deficiency in the two children. However, further efforts using complementary DNA (cDNA) derived from RNA from blood leukocytes identified a large deletion removing the entire exon 8, resulting in a frameshift and a premature stop codon (p.E371fsX372) in the mother and the two affected children. Our data indicate that if exon-by-exon DNA sequencing of genomic DNA does not uncover mutations corresponding to the phenotype, a systematic search for other mutations should be initiated by sequencing cDNA or using semiquantitative methods to detect large deletions in TCN2.
Literature
go back to reference Cooper BA, Rosenblatt DS (1987) Inherited defects of vitamin B12 metabolism. Annu Rev Nutr 7:291–320PubMedCrossRef Cooper BA, Rosenblatt DS (1987) Inherited defects of vitamin B12 metabolism. Annu Rev Nutr 7:291–320PubMedCrossRef
go back to reference Gustafsson B, Karpati F, Nordenstrom A, Soderhall S, Sander B, Nordvall M et al (2007) Myelodysplastic features and symptoms mimicking cystic fibrosis in a child with an intracellular vitamin B 12 deficiency. Pediatr Blood Cancer 49:1054–1055PubMedCrossRef Gustafsson B, Karpati F, Nordenstrom A, Soderhall S, Sander B, Nordvall M et al (2007) Myelodysplastic features and symptoms mimicking cystic fibrosis in a child with an intracellular vitamin B 12 deficiency. Pediatr Blood Cancer 49:1054–1055PubMedCrossRef
go back to reference Haberle J, Pauli S, Berning C, Koch HG, Linnebank M (2009) TC II deficiency: avoidance of false-negative molecular genetics by RNA-based investigations. J Hum Genet 54:331–334PubMedCrossRef Haberle J, Pauli S, Berning C, Koch HG, Linnebank M (2009) TC II deficiency: avoidance of false-negative molecular genetics by RNA-based investigations. J Hum Genet 54:331–334PubMedCrossRef
go back to reference Huijgen HJ, Tegelaers FP, Schoenmakers CH, Pronk-Admiraal CJ, Ekema S (2004) Multicenter analytical evaluation of an enzymatic method for the measurement of plasma homocysteine and comparison with HPLC and immunochemistry. Clin Chem 50:937–941PubMedCrossRef Huijgen HJ, Tegelaers FP, Schoenmakers CH, Pronk-Admiraal CJ, Ekema S (2004) Multicenter analytical evaluation of an enzymatic method for the measurement of plasma homocysteine and comparison with HPLC and immunochemistry. Clin Chem 50:937–941PubMedCrossRef
go back to reference Isken O, Maquat LE (2007) Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev 21:1833–1856PubMedCrossRef Isken O, Maquat LE (2007) Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev 21:1833–1856PubMedCrossRef
go back to reference Khajavi M, Inoue K, Lupski JR (2006) Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14:1074–1081PubMedCrossRef Khajavi M, Inoue K, Lupski JR (2006) Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14:1074–1081PubMedCrossRef
go back to reference Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41–54PubMedCrossRef Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41–54PubMedCrossRef
go back to reference Li N, Rosenblatt DS, Kamen BA, Seetharam S, Seetharam B (1994a) Identification of two mutant alleles of transcobalamin II in an affected family. Hum Mol Genet 3:1835–1840PubMedCrossRef Li N, Rosenblatt DS, Kamen BA, Seetharam S, Seetharam B (1994a) Identification of two mutant alleles of transcobalamin II in an affected family. Hum Mol Genet 3:1835–1840PubMedCrossRef
go back to reference Li N, Rosenblatt DS, Seetharam B (1994b) Nonsense mutations in human transcobalamin II deficiency. Biochem Biophys Res Commun 204:1111–1118PubMedCrossRef Li N, Rosenblatt DS, Seetharam B (1994b) Nonsense mutations in human transcobalamin II deficiency. Biochem Biophys Res Commun 204:1111–1118PubMedCrossRef
go back to reference Morkbak AL, Pedersen JF, Nexo E (2005) Glycosylation independent measurement of the cobalamin binding protein haptocorrin. Clin Chim Acta 356:184–190PubMedCrossRef Morkbak AL, Pedersen JF, Nexo E (2005) Glycosylation independent measurement of the cobalamin binding protein haptocorrin. Clin Chim Acta 356:184–190PubMedCrossRef
go back to reference Namour F, Helfer AC, Quadros EV, Alberto JM, Bibi HM, Orning L et al (2003) Transcobalamin deficiency due to activation of an intra exonic cryptic splice site. Br J Haematol 123:915–920PubMedCrossRef Namour F, Helfer AC, Quadros EV, Alberto JM, Bibi HM, Orning L et al (2003) Transcobalamin deficiency due to activation of an intra exonic cryptic splice site. Br J Haematol 123:915–920PubMedCrossRef
go back to reference Nexo E (1998) Cobalamin binding proteins. In: Kräutler B, Arigoni D, Golding B (eds) Vitamin B12 and B12-proteins. Wiley-VCH, Weinheim, pp 461–475CrossRef Nexo E (1998) Cobalamin binding proteins. In: Kräutler B, Arigoni D, Golding B (eds) Vitamin B12 and B12-proteins. Wiley-VCH, Weinheim, pp 461–475CrossRef
go back to reference Nexo E, Christensen AL, Petersen TE, Fedosov SN (2000) Measurement of transcobalamin by ELISA. Clin Chem 46:1643–1649PubMed Nexo E, Christensen AL, Petersen TE, Fedosov SN (2000) Measurement of transcobalamin by ELISA. Clin Chem 46:1643–1649PubMed
go back to reference Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN (2002) Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 48:561–562PubMed Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN (2002) Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 48:561–562PubMed
go back to reference Obeid R, Morkbak AL, Munz W, Nexo E, Herrmann W (2006) The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birth. Clin Chem 52:263–269PubMedCrossRef Obeid R, Morkbak AL, Munz W, Nexo E, Herrmann W (2006) The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birth. Clin Chem 52:263–269PubMedCrossRef
go back to reference Prasad C, Rosenblatt DS, Corley K, Cairney AE, Rupar CA (2008) Transcobalamin (TC) deficiency-potential cause of bone marrow failure in childhood. J Inherit Metab Dis doi:10.1007/s10545-008-0864-3 Prasad C, Rosenblatt DS, Corley K, Cairney AE, Rupar CA (2008) Transcobalamin (TC) deficiency-potential cause of bone marrow failure in childhood. J Inherit Metab Dis doi:10.​1007/​s10545-008-0864-3
go back to reference Qian L, Quadros EV, Regec A, Zittoun J, Rothenberg SP (2002) Congenital transcobalamin II deficiency due to errors in RNA editing. Blood Cells Mol Dis 28:134–142PubMedCrossRef Qian L, Quadros EV, Regec A, Zittoun J, Rothenberg SP (2002) Congenital transcobalamin II deficiency due to errors in RNA editing. Blood Cells Mol Dis 28:134–142PubMedCrossRef
go back to reference Rasmussen K (1989) Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 35:260–264PubMed Rasmussen K (1989) Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 35:260–264PubMed
go back to reference Ratschmann R, Minkov M, Kis A, Hung C, Rupar T, Muhl A et al (2009) Transcobalamin II deficiency at birth. Mol Genet Metab 98:285–288PubMedCrossRef Ratschmann R, Minkov M, Kis A, Hung C, Rupar T, Muhl A et al (2009) Transcobalamin II deficiency at birth. Mol Genet Metab 98:285–288PubMedCrossRef
go back to reference Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4:311–323PubMedCrossRef Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4:311–323PubMedCrossRef
go back to reference Regec A, Quadros EV, Platica O, Rothenberg SP (1995) The cloning and characterization of the human transcobalamin II gene. Blood 85:2711–2719PubMed Regec A, Quadros EV, Platica O, Rothenberg SP (1995) The cloning and characterization of the human transcobalamin II gene. Blood 85:2711–2719PubMed
go back to reference Rosenblatt DS, Fenton WA (2001) Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver CR, Berning C, Valle D, Sly WS (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 3897–3933 Rosenblatt DS, Fenton WA (2001) Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver CR, Berning C, Valle D, Sly WS (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 3897–3933
go back to reference Sellner LN, Taylor GR (2004) MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 23:413–419PubMedCrossRef Sellner LN, Taylor GR (2004) MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 23:413–419PubMedCrossRef
go back to reference Wuerges J, Garau G, Geremia S, Fedosov SN, Petersen TE, Randaccio L (2006) Structural basis for mammalian vitamin B12 transport by transcobalamin. Proc Natl Acad Sci USA 103:4386–4391PubMedCrossRef Wuerges J, Garau G, Geremia S, Fedosov SN, Petersen TE, Randaccio L (2006) Structural basis for mammalian vitamin B12 transport by transcobalamin. Proc Natl Acad Sci USA 103:4386–4391PubMedCrossRef
Metadata
Title
Transcobalamin deficiency caused by compound heterozygosity for two novel mutations in the TCN2 gene: a study of two affected siblings, their brother, and their parents
Authors
Peter H. Nissen
Maria Nordwall
Elke Hoffmann-Lücke
Boe S. Sorensen
Ebba Nexo
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue Special Issue 3/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9145-z

Other articles of this Special Issue 3/2010

Journal of Inherited Metabolic Disease 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine